The decrease in IL-10 secretion induced by anti-Rac3 siRNA can also be explained by the action of Rac3 on ERK-2/NF-κB signaling, but its role in cancer aggressivity has been reported to be due mainly to an immunosuppression and also to its angiogenic activity [47]. The gene discussed is NFKB1; the disease is cancer.